During the consultation on the draft guidance Janssen, the manufacturer of the drug, submitted further information for the committee to consider.
This included a revised patient access scheme which involves providing the drug to the NHS at a discounted price, further information on which patients would benefit most and clarification on how many patients could receive the drug.
These factors enabled the committee to revise its preliminary recommendation and now recommend the drug for use on the NHS.
More top news
The mother of an ex-girlfriend of Arnis Zalkalns has told ITV News her daughter is "in shock" over his connection to the Alice Gross case.
A pilot scheme involving major record companies will begin this Friday. It is expected 20% of videos will be subject to a ratings warning.
Ever seen anything more eccentric? Bizarre innovations unearthed by a historian spanning 100 years.